Generali Asset Management’s Xylem XYL Stock Holding History

Generali Asset Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.65M	Buy	13,975 +223	+2%	+$25.7K	0.03%	302
2026 Q1	$1.64M	Buy	13,752 +302	+2%	+$39.6K	0.03%	327
2025 Q4	$1.83M	Buy	13,450 +268	+2%	+$38.5K	0.04%	318
2025 Q3	$1.94M	Buy	13,182 +945	+8%	+$131K	0.04%	314
2025 Q2	$1.58M	Sell	12,237 -12,576	-51%	-$1.52M	0.04%	360
2025 Q1	$2.96M	Buy	24,813 +14,728	+146%	+$1.83M	0.07%	237
2024 Q4	$1.17M	Buy	+10,085	New	+$1.28M	0.03%	354

Other funds holding XYL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Generali Asset Management's XYL Position: Q2 2026 in Review

Generali Asset Management increased its Xylem (XYL) stake by 1.6% in Q2 2026, buying an estimated $25.7K and bringing the position to 13,975 shares worth $1.65M. The position accounts for 0.03% of the portfolio, ranked #302.

Generali Asset Management first reported a position in XYL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.96M in Q1 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Generali Asset Management held 13,975 shares of Xylem worth $1.65M as of Q2 2026.
Generali Asset Management bought 223 Xylem shares in Q2 2026, an estimated $25.7K.
Xylem made up 0.03% of Generali Asset Management's portfolio in Q2 2026, its #302 holding.
Generali Asset Management first reported a position in Xylem in Q4 2024 and has held it in 7 quarters since.
Generali Asset Management's Xylem position peaked at $2.96M in Q1 2025.
1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.